Alleles of the inducible nitric oxide synthase locus (Nos2) cosegregated highly significantly (P < 0.0001) with blood pressure in an F2 population [F2(S x MNS), n = 171] derived from a cross of inbred Dahl salt-sensitive (S) rats with Milan normotensive rats (MNS). In contrast, alleles at the constitutive brain nitric oxide synthase locus (Nosl) did not cosegregate with blood pressure in several F2 populations. Nos2 was mapped on rat chromosome 10. Nine genetic markers, including the angiotensin-converting enzyme (Ace) and Nos2 loci spanning roughly 46 cM on rat chromosome 10, all cosegregated strongly with blood pressure in the F2(S x MNS) population. Nos2 showed the highest LOD score of 6.3. Ace and Nos2 are 30 cM apart. In an F2 population [F2(S x WKY), n = 159] derived from a cross of S rats with Wistar-Kyoto (WKY) rats, Nos2 alleles did (P = 0.0070), but Ace alleles did not (P = 0.91), cosegregate with blood pressure. We conclude that the Nos2 locus rather than the Nos] locus is a candidate for influencing blood pressure in the S rat. There are probably two separate but linked quantitative trait loci (QTL) for blood pressure on rat chromosome 10, one marked by Ace and the other marked by Nos2. In F2(S x MNS) functionally variant alleles at both QTL influence blood pressure, but in F2(S x WKY) only the QTL marked by Nos2 is segregating alleles influencing blood pressure. (J. Clin. Invest. 1995. 95:2170-2177.) Key words: genetic hypertension * rat chromosome 10 -endothelium-derived relaxing factor * quantitative trait loci * Milan normotensive rat
Introduction
Nitric oxide (NO) (1, 2) , possibly along with labile nitroso compounds, is thought to account for the activity of an endothelium-derived relaxing factor originally described by Furchgott and Zawadzki (3) . Since NO is unstable, its oxidized products nitrite and nitrate are usually assayed as indicators of NO production (4) . Using L-arginine as the substrate, three types of enzymes, known as nitric oxide synthase (NOS),' responsible for the production of NO have been purified from humans and the mouse (5-7) and cloned (8) (9) (10) (11) (12) . Two types of NOS, designated as NOS1 and NOS3, are constitutively expressed and are Ca2' and calmodulin dependent. The remaining type, designated as NOS2, is inducible and is Ca2' and calmodulin independent (13) . So far, only NOSI (8) and NOS2 (14) (15) (16) have been identified and cloned in the rat. NOS] (17), NOS2 (18, 19) , and NOS3 (18, (20) (21) (22) have been assigned to human chromosomes 12, 17, and 7, respectively. Nos2 has also been mapped to mouse chromosome 11 (23) and rat chromosome 10 (24) . Among its alleged physiological functions, such as aiding in cytotoxicity mediated by macrophages (25) (26) (27) ) and serving as a neurotransmitter (25) (26) (27) (28) , NO can regulate blood pressure by causing vasodilation (1-3, 25-27, 29) .
It is unknown whether genetic variation in the NO synthesizing enzymes is involved in causing inherited hypertension. To address this issue, we utilized a genetic approach using genetically hypertensive inbred Dahl salt-sensitive rats in segregating populations to analyze the NO synthesizing enzymes for cosegregation with blood pressure.
Methods
Animal procedures. Rat strains used and animal procedures were given in detail previously (30) (31) (32) (33) and are only summarized briefly here. The inbred Dahl salt-sensitive and inbred Dahl salt-resistant rats were bred in our own colonies and will be designated as S and R, respectively. To generate segregating F2 populations, S rats were crossed with various contrasting strains and the F1 offspring were intercrossed to produce F2. The F2 rats were weaned at 30 d of age and fed on a high salt (8% NaCl) diet (TD82050, Teklad, Madison, WI) starting at 37 d of age. Systolic blood pressure was measured by the tail-cuff microphonic manometer method with the rats warmed to 28°C either under light ether anesthesia or in the conscious restrained state (IITC Inc., Woodland Hills, CA). When the highest blood pressures of rats in the population reached over 200 mmHg, the blood pressure of the entire population was measured intensively during a 7-l0-d period. At least three consistent blood pressure readings at a given session were acquired for each rat and averaged as that session's reading. Three such separate sessions on different days were conducted for each rat. The blood pressure from three sessions was then averaged and taken as the final blood pressure measurement of that rat. All rats were males, except for those crosses with R rats, in which case both male and female rats were studied. Data from males and females were combined in the present analysis as both sexes gave similar results.
Generation ofpolymorphic markers containing simple-sequence repeats (SSR) for rat NOS genes. A cDNA probe for the rat brain nitric oxide synthase (Nosi) was provided by Dr. S. Snyder (Johns Hopkins University, Baltimore, MD), and a cDNA probe for the mouse inducible nitric oxide synthase (Nos2) was provided by Dr. C. Nathan (Cornell University, New York).
A cDNA probe for the bovine endothelial nitric oxide synthase (Nos3) was generated as follows from a bovine endothelial cell cDNA library constructed in Xgtl 1, which was custommade by Clontech Laboratory Inc. (Palo Alto, CA). A pair of primers flanked by EcoRI restriction sites was designed to produce a product of 422 bp by PCR from the bovine endothelial Nos3 gene according to a published sequence (11). The forward primer was 5 'GGAATTCGATCAGCAACGCTA-TCACGA3' and the reverse primer was 5'GGAATTCTCACCTAA-ACACCAAAGGGC3'. The PCR product of the expected size was produced, separated on an 1.5% agarose gel, excised, purified using glass milk (Bio. 101, La Jolla, CA), and subcloned into a TA cloning vector (Invitrogen, San Diego, CA). The sequence of the PCR product was confirmed to be the bovine Nos3 sequence as published (11).
The cDNA probes for Nosi, Nos2, and Nos3 were then used to screen a genomic library (courtesy of Dr. D. Ginn [34] ) of the Dahl R rat. Probes were labeled using a kit for random priming (Boehringer Mannheim, Indianapolis, IN) and purified using a Bio-6 column (BioRad, Mellville, NY). Standard procedures for growing phage, screening by filter lift, treatment of DNA on the filters, and hybridization were used (35) . The Purified phage clones containing the rat Nos genes were prepared in a 2x NZCYM liquid medium by the standard method (35) . The inserts were digested separately with a series of restriction enzymes that cut the vector only once. The digested fragments were then separated on a 1% agarose gel, transferred to a sheet of Duralon-UV membrane (Stratagene, La Jolla, CA), fixed by UV cross-linking and probed with a mixture of (CA)15 and (CT)15 oligonucleotides. The oligonucleotides were end labeled with 32P as described previously (30) . Prehybridization and hybridization were carried out as described above.
The genomic fragments recognized by the (CA)15 and/or (CT)15 oligonucleotides were then subcloned into a pT7T3 18U (Pharmacia LKB Biotechnology Inc., Piscataway, NJ). The subcloned fragments containing (CA)n and/or (CT)n SSR in or near the gene for Nos] and Nos2 were digested with different enzymes followed by subcloning until the fragment of interest became < 1 kb. These clones were then sequenced. Flanking sequences around (CA)n and/or (CT)n repeats were used to design primers for PCR using the Primer Detective Program (Clontech). PCR of the SSR was done as given previously (30) except that labeled primers were used directly without purification. Briefly, the PCR program was run on a Thermocycler (M.J. Research, Watertown, MA). The PCR cycles for rat primers were as follows: 95TC for 5 min; 30 cycles of 94°C for 40 s, 55°C for 40 s, and 72°C for 1.5 min; extension for 5 min at 72°C. The PCR cycles for mouse primers were the same as above except the annealing temperature was set at 50°C rather than 55°C.
To verify that the genomic region containing the SSR was continuous and closely linked being the Nos gene in question rather than being a chimera formed by ligating unlinked random genomic fragments during cloning, all the clones positive for both a gene of interest and for containing a SSR were digested with restriction enzymes. Restriction mapping revealed that all such positive clones shared a similar restriction pattern and overlapped one another. Therefore, they were all cloned from the same chromosomal region. SSR PCR primers around SSR for both the rat Nos] and Nos2 genes are given in Table I .
Statistical analysis for genotyping and linkage. To eliminate genotyping errors, all homozygous genotypes were confirmed by retesting.
When several loci on a particular chromosome region were genotyped, the MAPMAKER program (36) was used to detect potential genotyping errors. If such possible errors were noted, the rats for the loci in question were genotyped again to either confirm or correct the results from the original genotyping.
A one-way ANOVA comparing blood pressure among segregating genotypes was done using SPSS programs (SPSS, Chicago, IL). Linkage maps and quantitative trait locus (QTL) localization were done with MAPMAKER/QTL programs (36, 37) obtained from Dr. Eric Lander (Whitehead Institute, Cambridge, MA). In QTL analysis of blood pressure in the rat, Jacob et al. (38) suggested that a LOD score of 3 or a probability from ANOVA of P < 0.001 should be set as the significance level to reasonably establish the existence of a QTL when many marker loci are screened.
Results
Cosegregation analysesfor Nosl and Nos2. Rat genomic clones for Nosi and Nos2 were obtained by screening the rat genomic library. But no rat genomic clones were obtained using the bovine Nos3 probe even under lower stringency conditions for both hybridization (370C) and the final wash (420C). Our attention was then focused on the rat Nosl and Nos2 loci.
Using the SSR markers we developed (Table I) , we genotyped the Nosl and Nos2 loci for cosegregation with blood pressure in F2 populations derived from crosses of the S rat with various control rats. Alleles of Nos2 cosegregated significantly with blood pressure in the F2(S X MNS) population (P < 0.0001) and in the F2(S x WKY) population (P = 0.007), but not in F2(S X R) or a backcross population F1 (S x R) X S (Table II) . We tested as many F2 populations as polymorphisms allow between the S and contrasting alleles for Nosl. No association between the alleles of Nosi and blood pressure has been detected in any of the four F2 populations tested (Table III) .
The rat Nosl gene could not be assigned to a rat chromosome by using rat-mouse somatic hybrids due to a lack of marker polymorphisms between the rat Nosl and the mouse Nosi genes nor was the rat Nosl gene linked to any markers we have genotyped thus far (30) (31) (32) (33) (34) . Thus, the chromosome localization of Nosl in the rat remains to be determined.
Genetic mapping ofthe Nos2 locus. We previously assigned Nos2 to rat chromosome 10 in mouse-rat somatic hybrids using a different SSR marker for Nos2 (24) . To further map Nos2 to a specific region of chromosome 10, we used two approaches to obtain more markers. The first approach was to map rat loci already assigned to chromosome 10 by linkage. Of 21 such rat loci containing SSR (Table I) , 8 were polymorphic between the S and MNS rats.
The second approach was to take advantage of a conserved synteny relationship between rat chromosome 10 and mouse chromosome 11 (39, 40) . We tested 141 mouse SSR markers for mouse chromosome 11 (purchased from Research Genetics, Huntsville, AL). Eight of them (5.6% of the total mouse markers tested) were polymorphic between S and MNS (Table I) . Of these eight mouse markers, six (4.2% of the total mouse markers tested) were usable for genotyping the rat F2(S x MNS) population as the other two mouse markers failed to yield PCR products for a majority of the rats in the population. Taken all together, 14 markers including Nos2 were analyzed for cosegregation with blood pressure and for linkage among themselves in the F2(S x MNS) population. The data for these loci are presented in Table II and Fig. 1 . These 14 markers fell When nine loci and their blood pressure effects were studied in F2(S x WKY) (Fig. 2) , a QTL with a smaller effect on blood pressure was detected near Nos2 with a maximum LOD score of 2.30. As opposed to the F2(S x MNS) population, alleles at the Ace locus in F2(S x WKY) did not cosegregate (P = 0.91) with blood pressure (Table II, Fig. 2 ) as reported previously (30) . Statistical analysis ofepistatic interaction between different loci. In our previous work (30) an interaction was observed between QTL associated with the guanylyl cyclase A/atrial natriuretic peptide receptor (Gca) locus on chromosome 2 and the Ace locus on chromosome 10 in the F2(S x MNS) population. In the present work, no interaction was found between Nos2 (30 cM from Ace) and markers on chromosome 2.
Discussion
A highly significant cosegregation of alleles at the Nos2 locus (P < 0.0001, F = 15.0, LOD = 6.4; Table II, Fig. 1 ) with systolic blood pressure in F2(S X MNS) provides strong evidence for a possible role of the inducible nitric oxide synthase (NOS2) in genetic hypertension in the S rat. In contrast, a constitutive and Ca2+ -dependent nitric oxide synthase (NOSI) may not be involved in genetic hypertension because alleles at the Nos] locus did not cosegregate with blood pressure in any of the four F2 populations tested (Table III) .
The results of physiological and pharmacological studies are pertinent to our genetic analysis. In studying both young S and R rats raised on a high-salt (8% NaCl) diet, Chen and italics. a-c, primers for markers were the same as given in references 38, 56, and 57, respectively. Abp, androgen binding protein; Aldoc, aldolase C, primers for PCR and its localization to rat chromosome 10 were reported previously (24) Sanders (41) showed that L-arginine, the substrate for NOS, but not D-arginine, caused a decrease in blood pressure in the S rat but not in the R rat when infused intravenously. N0-monomethyl-L-arginine, a relatively stereospecific competitive inhibitor of NOS, raised blood pressure more in the R rat than in the S rat. L-Arginine did not lower blood pressure in the S rat fed on a low-salt (0.3% NaCl) diet. Their results suggested that NOS (s) is likely involved in the regulation of blood pressure in the Dahl rats fed on a high-salt diet and the S rat may be defective in raising the activity of NOS compared with the R rat in response to a high-salt diet. The S rat appeared to be unique among hypertensive rat models in using the NO system because intravenous injection of L-arginine had no effect on blood pressure in the SHR (41) . Furthermore, a comparison of NO released and hypotensive effects in response to a bolus injection of acetylcholine, a stimulator of NO production, showed that there was no difference between the SHR rat and its regularly used normotensive control WKY rat (42) . Nmonomethyl-L-arginine increased blood pressure in a similar magnitude in both SHR and WKY (42) . Studies by Chen and Sanders (43) showed that the L-arginine-induced decrease in blood pressure in the S rat fed on a high-salt diet could be prevented by infusion of dexamethasone, a selective inhibitor for the expression of NOS2, but not of NOSI and NOS3 (44) . Thus, it appeared that NOS2, rather than NOSI or NOS3, was involved in pathogenesis of hypertension in the S rat. Several caveats need to be added to the genetic and physiological interpretations. A cosegregation analysis did not, and cannot, prove that the Nos2 locus, rather than an unknown locus linked to Nos2, was the actual QTL for blood pressure Values are means±SEM with number of rats for each genotype in parentheses. Primers and cosegregation data for Ace in F2(S X MNS) and F2(S x WKY) were also given previously (30) . In F2(S X MNS) and F2(S x WKY) populations, loci are given in the same order as they are on the linkage maps. For designations of the loci and for designations of rat strains, see the footnote for Table I . L, allele for the LEW strain; M, allele for the MNS strain; R, allele for the R strain; S, allele for the S strain; W, allele for the WKY strain.
on chromosome 10. L-Arginine, also a substrate for arginase in the urea cycle (45), may lower blood pressure of the S rat by a totally unknown mechanism other than being the substrate for NOS. Dexamethasone, although a selective inhibitor for NOS2 (not NOSI and NOS3), is not a specific inhibitor for NOS2 and can also inhibit the production of the vasodilator, atrial natriuretic peptide (46) . Furthermore, dexamethasone can inhibit the induction of arginino-succinate synthase, an enzyme involved in regeneration of arginine from citrulline (47) . Also, S rats were compared with R rats in the physiological studies cited. Physiological inferences involving the NO system dependent on an S versus R comparison are probably irrelevant because alleles of Nos2 did not cosegregate with blood pressure in F2(S x R) or F1(S X R) X S rats. Nevertheless, combining the physiological data relevant to the S rat per se with our genetic evidence, it is within reason to hypothesize that the production of NOS2 in the S rat, as compared with the MNS and/or WKY rat, might be defective in response to the stimulation by a high-sodium chloride (8%) diet. If so, insufficient NO would be generated in tissues involved in regulating blood pressure of the S rat.
Our other previous work at chromosome mapping of blood pressure QTL showed that there are chromosome regions on rat chromosomes 2 (32), 5 (31) , and 17 (31) , where single blood pressure QTL were identifiable, and that there were two separate and distinguishable blood pressure QTL in a region on rat chromosome 1 (48) . Typically, it has been possible to localize the QTL to regions 20-30 cM in size. In contrast, the markers spanning the entire chromosome region of roughly 46 cM between DlIMIT58 and MIT-R1704 on rat chromosome 10 (Fig. 1 ) all cosegregated strongly with blood pressure in F2(S X MNS) (P < 0.0001, F > 11.8 throughout this region). One interpretation is that on rat chromosome 10, there might exist two major blood pressure QTL so closely linked that they Studies in some human populations did not find an association of the ACE locus with essential hypertension (50) (51) (52) , whereas an insertion/deletion polymorphism of ACE showed an association with essential hypertension in another study population (53, 54) . Likely explanations were the ACE locus might not be a blood pressure QTL in humans, or the ACE locus failed to cosegregate with blood pressure in the particular human populations tested due to the nature of population dependence in cosegregation analysis (30) (31) (32) (33) , or the association of the ACE alleles with essential hypertension could be an agedependent phenomenon (55) . However, the positive and strong cosegregation of the Nos2 locus, 30 cM away from Ace, with blood pressure in the F2(S X MNS) and F2(S X WKY) populations, indicates that a blood pressure QTL might be near or identical to Nos2. It is, therefore, logical to test the NOS2 locus for cosegregation with blood pressure in human populations.
